10/15/12 -- The tragic circumstances surrounding the activities of New England Compounding Center (NECC) continue to grow. Today, the FDA MedWatch system released a new alert that two additional NECC products may be implicated in the development of patient infections. They are cardiologic solution and triamcinolone acetonide.
Please read the FDA announcement and share this information with the physicians, clinics, hospitals and others with whom you do business. If they have not removed any and all NECC labeled product from their inventory, they should do so immediately. No NECC labeled product should be used in patient care. All NECC labeled products have officially been recalled.
For a list of medications manufactured/distributed by NECC and subject to the total product recall, please click here.
Adverse reactions or quality problems experienced with the use of any product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
Stay connected to IACP by joining our online communities!